Global Antithyroid Drug Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Antithyroid Drug Market Research Report 2024
Antithyroid drug is a drug for the treatment of hyperthyroidism. It mainly reduces the secretion of thyroid hormone by inhibiting thyroid synthesis.
According to Mr Accuracy reports’s new survey, global Antithyroid Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Antithyroid Drug market research.
The next decade will be full of promise in thyroid cancer diagnosis and treatment.With the increasing incidence of thyroid cancer, the scientific cognition of professionals and the public will also be further improved. There will be more investment in basic research, more targeted drugs will be developed and better drug efficacy will be achieved.Therefore, the anti-thyroid drug market still has a lot of room for growth in the future.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antithyroid Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Shanghai Huanghai Pharmaceutical Co., Ltd
Merck KGaA
Lomapharm Rudolf Lohmann GmbH KG
Herbrand Pharmaceutical Chemistry Co., Ltd
Beijing Tongjida Pharmaceutical Co., Ltd
Shanghai Zhaohui Pharmaceutical Co., Ltd
Guangzhou Kanghe Pharmaceutical Co., Ltd
Hunan Hansen Pharmaceutical Co., Ltd
World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd
Haimani Pharmaceutical Co., Ltd
Shanghai McLin Biochemical Technology Co., Ltd
Shanghai Yuanye Bio-Technology Co., Ltd
Amgen Inc
AbbVie Deutschland GmbH & Co.KG
Centrix Pharmaceutical Inc.
Pfizer Inc.
Actavis Totowa LLC
Caraco Pharmaceutical Laboratories
Boca Pharmacal Inc.
Heritage Pharmaceuticals Inc.
Par Pharmaceutical Inc
Sandoz Pharmaceuticals Inc.
Segment by Type
Thiourea
Iodine and Iodide
Radioiodine
β Receptor Blockers
Medical Treatment of Hyperthyroidism
Preparation for Thyroid Surgery
Treatment of Thyroid Crisis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Antithyroid Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Antithyroid Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Antithyroid Drug market research.
The next decade will be full of promise in thyroid cancer diagnosis and treatment.With the increasing incidence of thyroid cancer, the scientific cognition of professionals and the public will also be further improved. There will be more investment in basic research, more targeted drugs will be developed and better drug efficacy will be achieved.Therefore, the anti-thyroid drug market still has a lot of room for growth in the future.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antithyroid Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
Shanghai Huanghai Pharmaceutical Co., Ltd
Merck KGaA
Lomapharm Rudolf Lohmann GmbH KG
Herbrand Pharmaceutical Chemistry Co., Ltd
Beijing Tongjida Pharmaceutical Co., Ltd
Shanghai Zhaohui Pharmaceutical Co., Ltd
Guangzhou Kanghe Pharmaceutical Co., Ltd
Hunan Hansen Pharmaceutical Co., Ltd
World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd
Haimani Pharmaceutical Co., Ltd
Shanghai McLin Biochemical Technology Co., Ltd
Shanghai Yuanye Bio-Technology Co., Ltd
Amgen Inc
AbbVie Deutschland GmbH & Co.KG
Centrix Pharmaceutical Inc.
Pfizer Inc.
Actavis Totowa LLC
Caraco Pharmaceutical Laboratories
Boca Pharmacal Inc.
Heritage Pharmaceuticals Inc.
Par Pharmaceutical Inc
Sandoz Pharmaceuticals Inc.
Segment by Type
Thiourea
Iodine and Iodide
Radioiodine
β Receptor Blockers
Segment by Application
Medical Treatment of Hyperthyroidism
Preparation for Thyroid Surgery
Treatment of Thyroid Crisis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Antithyroid Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
